FREE Webinar

Thursday, December 10, 2020
2:00 - 3:30 PM, Eastern Standard Time

Register Now

Cell and gene therapies are revolutionizing next-generation therapeutics. Many researchers are now leveraging the power of CRISPR precision genome engineering in their cell and gene therapies research, from fixing mutations associated with disease to modifying immune cells to attack cancer. In this webinar, brought to you by Synthego, cell and gene therapy experts will discuss the applications of CRISPR in studying genetic diseases and beyond.

Topics to be covered

  • Decoding and repairing genetic disease with CRISPR and iPSCs
  • The future of cell and gene therapy using CRISPR

Register Now

Meet the Speakers:

Robert Deans, PhD
Chief Scientific Officer
Synthego


Bruce Conklin, MD
Senior Investigator, Gladstone Institutes
Deputy Director, Innovative Genomics Institute
Professor, Departments of Medicine, Pharmacology, and Ophthalmology
University of California, San Francisco

genomics.png


Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?